Search Results:　 1-20 of 52693

Kitamura Mineaki , Nishino Tomoya , Obata Yoko , Furusu Akira , Hishikawa Yoshitaka , Koji Takehiko , Kohno Shigeru

… Based on preliminary examination, 2mL of 40mM MGO or PD fluid was injected intraperitoneally and EGCG (50mg/kg) or saline was injected subcutaneously for 3weeks. …

Chemico-Biological Interactions 195(1), 95-104, 2012-01-05

IR CrossRef

… 日時:平成22年12月16日会場:ホテルセントラーザ博多３階「花筺の間」学術情報提供 : 「イナビル吸入粉末剤20mg」第一三共株式会社主題『各科領域におけるESBLの現状』 : I．一般演題 座長福岡大学医学部呼吸器内科学准教授藤田昌樹 1．「当院におけるESBL産生菌の検討」 : 済生会福岡総合病院長﨑洋司2．「腸内細菌科の菌種におけるESBL産生菌の現状 : 尿路および膿検体中心に」 : 株式会社キューリン検査部部長村谷 …

福岡医学雑誌 102, 341-348, 2011-12-25

IR

KOBAYASHI Takashi , KOIZUMI Tomonobu , YASUO Masanori , TSUSHIMA Kenji , YAMAMOTO Hiroshi , KUBO Keishi

… Paclitaxel (150 mg/m2) and gemcitabine (1,000 mg/m2) were administered biweekly for at least 4 cycles. …

信州医学雑誌 59(6), 411-418, 2011-12-10

IR

Inomata Shoko , Ito Sachiko U , Wakasa Masahiko , Osawa Yukihiko , Shimizu Kazumi , Ito Wakako , Kanbayashi Takashi , Shimizu Tetsuo

… Triazolam0.125 mg, rilmazafone hydrochloride 1 mg or placebo was orally given to each subjectbefore going to bed (11 pm). …

秋田医学 38(2), 63-69, 2011-12

IR

井上 勝己 , 下村 貴宏 , 賀本 敏行

… 1-mg tablet after single oral administration in healthy men. …

泌尿器科紀要 57(12), 677-681, 2011-12

IR

Tada Hayato , Kawashiri Masa-aki , Ohtani Rumiko , Noguchi Tohru , Nakanishi Chiaki , Konno Tetsuo , Hayashi Kenshi , Nohara Atsushi , Inazu Akihiro , Kobayashi Junji , Mabuchi Hiroshi , Yamagishi Masakazu

… mg/dl). …

Atherosclerosis 219(2), 663-666, 2011-12

IR CrossRef

Tada Hayato , Kawashiri Masa-aki , Ohtani Rumiko , Noguchi Tohru , Nakanishi Chiaki , Konno Tetsuo , Hayashia Kenshi , Nohara Atsushi , Inazu Akihiro , Kobayashi Junji , Mabuchi Hiroshi , Yamagishi Masakazu

… Although the proband exhibited massive Achilles tendon xanthoma and coronary and aortic valvular disease, serum LDL-C level of subjects with double mutations was similar with that of subjects with single LDLR mutation (284.0 ± 43.5 versus 265.1 ± 57.4 mg/dl). …

Atherosclerosis 219(2), 663-666, 2011-12

IR CrossRef

Yamashita Tatsuya , Arai Kuniaki , Sunagozaka Hajime , Ueda Teruyuki , Terashima Takeshi , Yamashita Taro , Mizukoshi Eishiro , Sakai Akito , Nakamoto Yasunari , Honda Masao , Kaneko Shuichi

… FU (300 mg/m2, days 1–5, days 8–12) with or without CDDP (20 mg/m2, days 1 and 8) was administered via the hepatic artery. …

Oncology 81(5-6), 281-290, 2011-11-30

IR CrossRef

Fuchigami Takeshi , Haratake Mamoru , Magata Yasuhiro , Haradahira Terushi , Nakayama Morio

… Saturation assay in rat cortical membranes revealed that [(125)I]5 had a single high affinity binding site with a K(d) of 1.54nM and a B(max) of 3.40pmol/mg protein. …

Bioorganic & Medicinal Chemistry 19(21), 6245-6253, 2011-11-01

IR CrossRef